These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6818279)

  • 1. Influence of time, temperature and coagulation on the measurement of C3, C3 split products and C4.
    Sinosich MJ; Teisner B; Brandslund I; Fisher M; Grudzinskas JG
    J Immunol Methods; 1982 Nov; 55(1):107-14. PubMed ID: 6818279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating C3, C4, and C3 split products (C3c and C3d) during normal pregnancy.
    Teisner B; Hau J; Tucker M; Lahood J; Grudzinskas JG
    Am J Reprod Immunol (1980); 1982 Dec; 2(6):309-11. PubMed ID: 6984294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical pathway activation during an adverse response to protamine sulphate.
    Best N; Teisner B; Grudzinskas JG; Fisher MM
    Br J Anaesth; 1983 Nov; 55(11):1149-53. PubMed ID: 6605758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of complement activation by counterimmunoelectrophoresis (CIE).
    Arroyave CM; Tan EM
    J Immunol Methods; 1976; 13(2):101-12. PubMed ID: 824368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.
    Bourke BE; Moss IK; Maini RN
    J Immunol Methods; 1982; 48(1):97-108. PubMed ID: 6799579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera.
    Garratty G; Petz LD
    Transfusion; 1976; 16(4):297-306. PubMed ID: 951725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma.
    Brandslund I; Siersted HC; Svehag SE; Teisner B
    J Immunol Methods; 1981; 44(1):63-71. PubMed ID: 6166689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening test for complement activation by counterimmunoelectrophoresis.
    Arroyave CM; Taylor DG; Gallup P; Nakamura RM
    Am J Clin Pathol; 1978 Apr; 69(4):440-5. PubMed ID: 417620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d.
    Brandslund I; Teisner B; Hyltoft Petersen P; Svehag SE
    Scand J Clin Lab Invest Suppl; 1984; 168():57-73. PubMed ID: 6333715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin.
    Nielsen H; Sørensen H; Faber V; Svehag SE
    Scand J Immunol; 1978; 7(1):25-33. PubMed ID: 635471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoelectrophoretic analysis of C4 split products expressing D but not C epitopes: influence of storage, Ca2+ and Ca2+-chelating agents.
    Petersen NE; Folkersen J; Teisner B; Svehag SE
    Complement; 1985; 2(2-3):147-55. PubMed ID: 2417781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative changes in complement associated with cardiopulmonary bypass.
    Boralessa H; Shifferli JA; Zaimi F; Watts E; Whitwam JG; Rees AJ
    Br J Anaesth; 1982 Oct; 54(10):1047-52. PubMed ID: 6982053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA; Strauss LG; Georgi M
    Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method for quantitative measurement of C3d in human plasma.
    Bhakdi S; Roth M; Nürnberger W
    J Immunol Methods; 1984 Nov; 74(1):79-86. PubMed ID: 6438236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
    Zwirner J; Dobos G; Götze O
    J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement levels and C3 breakdown products in open-heart surgery: association of C3 conversion with the postpericardiotomy syndrome.
    Meri S; Verkkala K; Miettinen A; Valtonen V; Linder E
    Clin Exp Immunol; 1985 Jun; 60(3):597-604. PubMed ID: 3874733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.